MHRA – Yellow Card Scheme
FREE
The Yellow Card scheme is run by the MHRA and is the cornerstone of post market surveillance of healthcare products in the UK.
This collaboration between BPSA and the Medicines and Healthcare products Regulatory Agency (MHRA) is delivered as a 1-hour formative assessment, containing 2 modules:
- Module 1: ‘MHRA and the Yellow Card scheme’ – general knowledge questions about the role of the MHRA and the Yellow Card scheme; and
- Module 2: ‘Reporting Adverse Incidents’ – scenario based case studies about adverse incidents and reporting routes.
Each question is presented in an easy to follow, question-and-answer format, with access to immediate question-by-question feedback and links to further reading and relevant guidelines.
Through the Yellow Card scheme, the MHRA collects and monitors information on suspected safety concerns involving healthcare products, like side effects caused by a medicine, or adverse incidents involving medical devices.
The material in this assessment has been written and reviewed by content specialists from the MHRA. It is aimed at all healthcare professionals wishing to improve their knowledge of the regulatory function of the agency and why reporting suspected safety concerns to the Yellow Card scheme is important for patient safety.
By the end of this assessment, we hope you will be able to understand better the regulatory role of the agency, the importance of post-market surveillance activities in the real world and the value of reporting any suspected safety concerns to the Yellow Card scheme.
The package is delivered using the same technology and layout as the UK Prescribing Safety Assessment which is taken by over 7000 medical students annually and assesses prescribing competencies among those graduating into the UK Foundation Programme.
